Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
Blood Adv
; 7(1): 88-91, 2023 01 10.
Article
in En
| MEDLINE
| ID: mdl-36269847
Full text:
1
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell, Marginal Zone
/
Neoplasm Recurrence, Local
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2023
Type:
Article